SCHEMBL27409265

SCHEMBL27409265

CN(C)C(=O)c1c[nH]c2c(NCc3ccc(B(O)O)cc3)ncnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.38
CYP1A2 P05177 3/20 0.38
MAPK1 P28482 3/20 0.38
CYP3A4 P08684 2/20 0.38
HSD17B10 Q99714 2/20 0.38
LMNA P02545 2/20 0.38
CYP2D6 P10635 2/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2C19 P33261 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
AURKA O14965 10/20 0.37
RPS6KB1 P23443 10/20 0.37
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
OXTR P30559 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30097205 1.00 PRMT1 (0.38) PRMT1CYP1A2MAPK1CYP3A4HSD17B10
SCHEMBL27409242 0.86 AURKA (0.40) PRMT1CYP1A2MAPK1LMNACYP2D6
SCHEMBL27409830 0.86 RPS6KB1 (0.48) AURKARPS6KB1AURKB
SCHEMBL30097217 0.86 RPS6KB1 (0.48) AURKARPS6KB1AURKB
SCHEMBL30097138 0.84 PRMT1 (0.38) PRMT1CYP1A2MAPK1LMNACYP2D6
SCHEMBL27409273 0.84 PRMT1 (0.38) PRMT1CYP1A2MAPK1LMNACYP2D6
SCHEMBL27410371 0.84 EGFR (0.43) PRMT1MAPK1HSD17B10LMNAALDH1A1
SCHEMBL27409278 0.84 CCNB2 (0.39) PRMT1MAPK1AURKARPS6KB1CCNB2
SCHEMBL30097279 0.84 CCNB2 (0.39) PRMT1MAPK1AURKARPS6KB1CCNB2
SCHEMBL30097225 0.82 HDAC6 (0.36) PRMT1CYP1A2MAPK1LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS ENPP1, ENPP3, ENTPD5 PRMT1 1246/4885CYP1A2 1401/4885MAPK1 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.